BioWorld MedTech

Jan. 24, 2014

J.P. Morgan Healthcare Conference: Private ophthalmic companies make their pitches to receptive audience

SAN FRANCISCO — Although this annual conference has long been and continues to be dominated by publicly-owned healthcare companies, once again this year there was an impressive roster of attractive private companies. Read More

Medtronic gains approval for MRI to be used with pacing systems

Washington Roundup: FDA publishes draft to update 1998 animal materials guidance

Report from Asia: Trademark trouble follows J&J overseas to Chinese market

Deals roundup: Valeant tendered purchase of outstanding Solta shares

BioWorld Survey: Let Us Know What You Think!

Financings roundup: OrthoAccel Tech snags $5 million equity round

Agreements/contracts: KCI gets new designations from Novation for V.A.C.Ulta

Product briefs

People in Places

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...